Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide capsules versus placebo for maintenance of biochemical control in acromegaly
2017-000737-31Phase 3Unknown
- Sponsor
- Chiasma
- Start
- Jun 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of octreotide in acromegaly (2 arms), sponsored by Chiasma. Primary endpoint: Maintenance of biochemical response at end of double-blind placebo-controlled period. Status: unknown.
02
Drugs
octreotide
03
Conditions
acromegaly
Beyond the preview
Go deeper on 2017-000737-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000737-31.